Treatment of hyperprolactinaemia reduces total cholesterol and LDL in patients with prolactinomas

Previous studies suggest that hyperprolactinaemia might have adverse effects on lipid and glucose metabolism. We therefore aimed to evaluate whether dopamine agonist treatment with cabergoline has significant effects on blood lipids, fasting glucose and HbA1c levels in patients with micro- or macrop...

Full description

Saved in:
Bibliographic Details
Published in:Metab Brain Dis
Main Authors: Schwetz, Verena, Librizzi, Rosaria, Trummer, Christian, Theiler, Georg, Stiegler, Claudia, Pieber, Thomas R., Obermayer-Pietsch, Barbara, Pilz, Stefan
Format: Artigo
Language:Inglês
Published: Springer US 2016
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566581/
https://ncbi.nlm.nih.gov/pubmed/27525431
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11011-016-9882-2
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items